OBJECTIVE: The authors analyzed prescribing for antidepressant medications during 27,328 prenatal visits in ambulatory settings in the United States between 2002 and 2010. METHODS: Data from the 2002-2010 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey were used to compare prescribing for antidepressant medication during visits for outpatient prenatal care between 2002-2006 and 2007-2010. RESULTS: Prenatal visits associated with a prescription for an antidepressant increased from .7% in 2002-2006 to 2.1% in 2007-2010 (p<.01). The proportion of prescriptions for selective serotonin reuptake inhibitors (SSRIs) declined (from 87% to 66%, p=.04), particularly for paroxetine (from 19% to <1%, p<.01). CONCLUSIONS: Despite controversy over possible negative effects, prescribing of antidepressants during pregnancy increased between 2002 and 2010. SSRIs represented a smaller proportion of all antidepressants prescribed, and prescribing of paroxetine, likely in response to warnings by the U.S. Food and Drug Administration, dropped dramatically.
OBJECTIVE: The authors analyzed prescribing for antidepressant medications during 27,328 prenatal visits in ambulatory settings in the United States between 2002 and 2010. METHODS: Data from the 2002-2010 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey were used to compare prescribing for antidepressant medication during visits for outpatient prenatal care between 2002-2006 and 2007-2010. RESULTS: Prenatal visits associated with a prescription for an antidepressant increased from .7% in 2002-2006 to 2.1% in 2007-2010 (p<.01). The proportion of prescriptions for selective serotonin reuptake inhibitors (SSRIs) declined (from 87% to 66%, p=.04), particularly for paroxetine (from 19% to <1%, p<.01). CONCLUSIONS: Despite controversy over possible negative effects, prescribing of antidepressants during pregnancy increased between 2002 and 2010. SSRIs represented a smaller proportion of all antidepressants prescribed, and prescribing of paroxetine, likely in response to warnings by the U.S. Food and Drug Administration, dropped dramatically.
Authors: Shannon M Gaukler; James S Ruff; Tessa Galland; Kirstie A Kandaris; Tristan K Underwood; Nicole M Liu; Elizabeth L Young; Linda C Morrison; Garold S Yost; Wayne K Potts Journal: Neurotoxicol Teratol Date: 2014-11-12 Impact factor: 3.763
Authors: April L Dawson; Hilda Razzaghi; Annelise Arth; Mark A Canfield; Samantha E Parker; Jennita Reefhuis Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-04-17
Authors: Jean Y Ko; Karilynn M Rockhill; Van T Tong; Brian Morrow; Sherry L Farr Journal: MMWR Morb Mortal Wkly Rep Date: 2017-02-17 Impact factor: 17.586
Authors: Xiali Zhong; Georgina Harris; Lena Smirnova; Valentin Zufferey; Rita de Cássia da Silveira E Sá; Fabiele Baldino Russo; Patricia Cristina Baleeiro Beltrao Braga; Megan Chesnut; Marie-Gabrielle Zurich; Helena T Hogberg; Thomas Hartung; David Pamies Journal: Front Cell Neurosci Date: 2020-02-21 Impact factor: 5.505